Evidence map›Paper›PMID 33164745›Full record

ArticleeLife2020

Mucosal-associated invariant T (MAIT) cells mediate protective host responses in sepsis.

Shubhanshi Trivedi, Daniel Labuz, Cole P Anderson, Claudia V Araujo, Antoinette Blair, Elizabeth A Middleton, Owen Jensen, Alexander Tran, Matthew A Mulvey, Robert A Campbell and 3 more

Open access · goldAbstract read
In one paragraph

Article in eLife, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Destabilisation of T cell-dependent humoral immunity in sepsis.Clinical science (London, England : 1979) · 2024
    Review
  13. Article
  14. Article
  15. Article
  16. Human MAIT Cells Respond toMicroorganisms · 2022
    Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Shubhanshi TrivediDivision of Infectious Diseases, University of Utah, Salt Lake City, United States.
Daniel LabuzDivision of Infectious Diseases, University of Utah, Salt Lake City, United States.
Cole P AndersonDivision of Infectious Diseases, University of Utah, Salt Lake City, United States.
Claudia V AraujoMolecular Medicine Program, University of Utah, Salt Lake City, United States.
Antoinette BlairMolecular Medicine Program, University of Utah, Salt Lake City, United States.
Elizabeth A MiddletonMolecular Medicine Program, University of Utah, Salt Lake City, United States.
Owen JensenDivision of Infectious Diseases, University of Utah, Salt Lake City, United States.
Alexander TranDivision of Microbiology and Immunology, Department of Pathology, University of Utah, Salt Lake City, United States.
Matthew A MulveyDivision of Microbiology and Immunology, Department of Pathology, University of Utah, Salt Lake City, United States.
Robert A CampbellMolecular Medicine Program, University of Utah, Salt Lake City, United States.
J Scott HaleDivision of Microbiology and Immunology, Department of Pathology, University of Utah, Salt Lake City, United States.
Matthew T Rondina *Molecular Medicine Program, University of Utah, Salt Lake City, United States.
Daniel T Leung *Division of Infectious Diseases, University of Utah, Salt Lake City, United States.ORCID 0000-0001-8401-0801
University of Utah · US

Funding

Utah Center for Clinical and Translational ScienceUL1TR002538 · NCATS · UNIVERSITY OF UTAH · PI HESS, RACHEL, MAJERSIK, JENNIFER JUHL · 2018 to 2022
$26.0M
Training Program in Genomic MedicineT32HG008962 · NHGRI · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI Lynn Jorde, Aaron R Quinlan · 2016 to 2026
$3.0M
Translational Control of Megakaryocyte and Platelet Function in SepsisR01HL142804 · NHLBI · UNIVERSITY OF UTAH · PI RONDINA, MATTHEW THOMAS · 2018 to 2021
$1.9M
Mucosal associated invariant T (MAIT) cells in Vibrio cholerae infection and vaccinationR01AI130378 · NIAID · UNIVERSITY OF UTAH · PI LEUNG, DANIEL TED · 2017 to 2021
$1.8M
Platelet Immune Responses in Aging and InfluenzaR01AG048022 · NIA · UNIVERSITY OF UTAH · PI RONDINA, MATTHEW THOMAS · 2014 to 2018
$1.8M
Impact of Flagellin Variants and Receptors on the Progression and Outcome of SepsisR01GM134331 · NIGMS · UNIVERSITY OF UTAH · PI MULVEY, MATTHEW A · 2019 to 2022
$1.6M
NRSA Training CoreTL1TR002540 · NCATS · UNIVERSITY OF UTAH · PI FAGERLIN, ANGELA, FAIRFAX, KEKE CELESTE · 2018 to 2022
$1.6M
Novel Platelet Functions in Sepsis and Venous ThromboembolismK23HL092161 · NHLBI · UNIVERSITY OF UTAH · PI RONDINA, MATTHEW THOMAS · 2009 to 2013
$775k
Interferon-Induced Transmembrane Protein 3 (IFITM3) Regulates Thrombosis During Inflammation in AgingK01AG059892 · NIA · UNIVERSITY OF UTAH · PI CAMPBELL, ROBERT A · 2019 to 2022
$400k
The Regulation of Inflammatory Gene Responses in AgingR03AG040631 · NIA · UNIVERSITY OF UTAH · PI RONDINA, MATTHEW THOMAS · 2011 to 2012
$149k
Platelet Reprogramming During InflammationI01CX001696 · VA · VA SALT LAKE CITY HEALTHCARE SYSTEM · PI Matthew Thomas Rondina · 2018 to 2026
–
CSRD VA I01 CX001696NCATS NIH HHS TL1 TR002540NCATS NIH HHS UL1 TR002538NHGRI NIH HHS T32 HG008962NHLBI NIH HHS K23 HL092161NIAID NIH HHS R01 AI130378NIA NIH HHS K01 AG059892NIA NIH HHS R01 AG048022NIA NIH HHS R03 AG040631NIGMS NIH HHS R01 GM134331
6 · The paper itself

Abstract

Sepsis is a systemic inflammatory response to infection and a leading cause of death. Mucosal-associated invariant T (MAIT) cells are innate-like T cells enriched in mucosal tissues that recognize bacterial ligands. We investigated MAIT cells during clinical and experimental sepsis, and their contribution to host responses. In experimental sepsis, MAIT-deficient mice had significantly increased mortality and bacterial load, and reduced tissue-specific cytokine responses. MAIT cells of WT mice expressed lower levels of IFN-γ and IL-17a during sepsis compared to sham surgery, changes not seen in non-MAIT T cells. MAIT cells of patients at sepsis presentation were significantly reduced in frequency compared to healthy donors, and were more activated, with decreased IFN-γ production, compared to both healthy donors and paired 90-day samples. Our data suggest that MAIT cells are highly activated and become dysfunctional during clinical sepsis, and contribute to tissue-specific cytokine responses that are protective against mortality during experimental sepsis.

Indexed as

AnimalsBiomarkersCytokinesFemaleHistocompatibility Antigens Class IHumansImmunity, InnateMaleMiceMice, Inbred C57BLMice, KnockoutMiddle AgedMinor Histocompatibility AntigensMucosal-Associated Invariant T CellsRNA, MessengerSepsisBiomarkersCytokinesHistocompatibility Antigens Class IMinor Histocompatibility AntigensMr1 protein, mouseRNA, Messengerhumanimmunologyinflammationinnate-like T cellMAIT cellsmedicinemousesepsis

Identifiers

PMID33164745
PMCPMC7679140
OpenAlexW3103699740

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.